Frequently Asked Questions
The market is segmented based on , By Diseases Type (Benign Rolandic Epilepsy, Infantile Spasms, Lennox-Gastaut Syndrome, Others), Therapeutics (Surgical Therapies, Dietary Supplements, Vagal Nerve Stimulation, Others), End-Users (Hospitals, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, online Pharmacies and Others) – Industry Trends and Forecast to 2030.
.
The Global Paediatric Epilepsy Therapeutics Market size was valued at USD 11.45 USD Billion in 2022.
The Global Paediatric Epilepsy Therapeutics Market is projected to grow at a CAGR of 5% during the forecast period of 2023 to 2023.
The major players operating in the market include GSK, Pfizer, Medtronic, UCB, NeuroPace, Jazz Pharmaceuticals, Novartis, Johnson & Johnson, Abbott, Sage Therapeutics, Sunovion Pharmaceuticals, Sanofi, Bausch Health Companies, Amneal Pharmaceuticals.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
